Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk obesity drug results underwhelm investors
Novo Nordisk obesity drug results underwhelm investors
Novo Nordisk obesity drug results underwhelm investors
Submitted by
admin
on March 19, 2013 - 11:02am
Source:
Reuters
News Tags:
obesity
Novo Nordisk
liraglutide
Headline:
Novo Nordisk obesity drug results underwhelm investors
Do Not Allow Advertisers to Use My Personal information
